Hotchkis & Wiley Capital Management LLC Has $9.19 Million Stock Holdings in TriMas Corporation $TRS

Key Points

• Hotchkis & Wiley Capital Management LLC increased its holdings in TriMas Corporation by 34.5%, owning 392,210 shares valued at approximately $9.19 million as of the latest SEC filing.
• TriMas reported a 14.2% year-over-year increase in quarterly revenue, with earnings per share at $0.61, exceeding expectations and setting FY 2025 guidance between $1.950 and $2.100 EPS.
• Research analysts have raised TriMas's stock rating to "buy", with a consensus price target of $45.00, reflecting increased investor confidence.

Hotchkis & Wiley Capital Management LLC increased its holdings in shares of TriMas Corporation (NASDAQ:TRS - Free Report) by 34.5% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 392,210 shares of the industrial products company's stock after purchasing an additional 100,610 shares during the quarter. Hotchkis & Wiley Capital Management LLC owned 0.96% of TriMas worth $9,189,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Tribune Investment Group LP acquired a new position in shares of TriMas in the first quarter valued at approximately $1,757,000. Roubaix Capital LLC acquired a new position in TriMas in the 1st quarter worth $4,955,000. Raymond James Financial Inc. increased its holdings in TriMas by 34.8% during the 1st quarter. Raymond James Financial Inc. now owns 367,215 shares of the industrial products company's stock worth $8,604,000 after purchasing an additional 94,834 shares in the last quarter. American Century Companies Inc. raised its stake in shares of TriMas by 9.1% in the 1st quarter. American Century Companies Inc. now owns 86,017 shares of the industrial products company's stock valued at $2,015,000 after purchasing an additional 7,141 shares during the period. Finally, Nuveen LLC acquired a new stake in shares of TriMas in the 1st quarter valued at about $5,932,000. Institutional investors own 99.42% of the company's stock.

Insider Buying and Selling

In other news, Director Adrianne Shapira purchased 4,000 shares of the business's stock in a transaction on Thursday, June 5th. The stock was purchased at an average price of $25.82 per share, for a total transaction of $103,280.00. Following the completion of the purchase, the director directly owned 8,476 shares in the company, valued at $218,850.32. The trade was a 89.37% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have acquired a total of 5,266 shares of company stock valued at $137,188 in the last ninety days. Company insiders own 14.20% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Wall Street Zen raised TriMas from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st. KeyCorp set a $45.00 price target on TriMas and gave the stock an "overweight" rating in a research report on Tuesday, August 12th. Finally, BWS Financial reaffirmed a "buy" rating and set a $45.00 price target (up from $40.00) on shares of TriMas in a research note on Wednesday, July 30th. Two equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $45.00.

TriMas Stock Performance

Shares of NASDAQ TRS opened at $38.33 on Monday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.44 and a current ratio of 2.59. The stock has a 50 day moving average price of $31.92 and a 200 day moving average price of $26.54. The stock has a market capitalization of $1.56 billion, a PE ratio of 42.12 and a beta of 0.66. TriMas Corporation has a 52 week low of $19.33 and a 52 week high of $38.56.

TriMas (NASDAQ:TRS - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The industrial products company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.11. The firm had revenue of $274.76 million for the quarter, compared to analyst estimates of $251.18 million. TriMas had a return on equity of 11.49% and a net margin of 3.83%.The business's quarterly revenue was up 14.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.43 EPS. TriMas has set its FY 2025 guidance at 1.950-2.100 EPS. Analysts predict that TriMas Corporation will post 1.69 earnings per share for the current fiscal year.

TriMas Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, August 12th. Shareholders of record on Tuesday, August 5th were given a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend was Tuesday, August 5th. TriMas's dividend payout ratio is 17.58%.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Corporation (NASDAQ:TRS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.